Transfer factor: a potential agent for immunotherapy of cancer
- PMID: 272085
- DOI: 10.1007/BF01556190
Transfer factor: a potential agent for immunotherapy of cancer
Similar articles
-
Editorial: Transfer factor therapy: current status.South Med J. 1975 Dec;68(12):1465-7. doi: 10.1097/00007611-197512000-00001. South Med J. 1975. PMID: 1060179 No abstract available.
-
BCG, levamisole and transfer factor in the treatment of cancer.Prog Exp Tumor Res. 1980;25:178-92. doi: 10.1159/000403181. Prog Exp Tumor Res. 1980. PMID: 6986631 Review. No abstract available.
-
Chemoimmunotherapy of human solid tumors.Med Clin North Am. 1976 May;60(3):441-62. doi: 10.1016/s0025-7125(16)31891-0. Med Clin North Am. 1976. PMID: 1063907 No abstract available.
-
Postsurgical adjuvant chemotherapy: a review.Surg Annu. 1981;13:31-52. Surg Annu. 1981. PMID: 7025285 Review. No abstract available.
-
Effects of large doses of dialysable leukocyte extract.Proc Soc Exp Biol Med. 1980 Oct;165(1):91-5. doi: 10.3181/00379727-165-40939. Proc Soc Exp Biol Med. 1980. PMID: 6968440 No abstract available.
Cited by
-
Clinical and immunological assessment in breast cancer patients receiving anticancer therapy and bovine dialyzable leukocyte extract as an adjuvant.Exp Ther Med. 2010 May;1(3):425-431. doi: 10.3892/etm_00000066. Epub 2010 May 1. Exp Ther Med. 2010. PMID: 22993557 Free PMC article.